| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/04/2010 | US20100028449 Fermented milk product and use thereof |
| 02/04/2010 | US20100028431 Compositions and methods for therapeutic use |
| 02/04/2010 | US20100028424 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; vaccine development for hepatitis B virus, HIV, bacteria, parasites, and viruses |
| 02/04/2010 | US20100028417 Use of substituted glycerin derivatives for producing a pharmaceutical preparation |
| 02/04/2010 | US20100028414 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy |
| 02/04/2010 | US20100028381 Formulation for delivery of immune response modifiers |
| 02/04/2010 | US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 02/04/2010 | US20100028373 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 02/04/2010 | US20100028371 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 02/04/2010 | US20100028368 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof |
| 02/04/2010 | US20100028367 Sgp130/fc dimers |
| 02/04/2010 | US20100028365 Methods and compositions for the diagnosis and treatment of cancer |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028347 Antibodies against vascular endothelial growth factor receptor-1 |
| 02/04/2010 | US20100028346 Novel synergistic effects |
| 02/04/2010 | US20100028339 Compositions including triciribine and trastuzumab and methods of use thereof |
| 02/04/2010 | US20100028338 Gimatecan (7-t-butoxyiminomethylcamptothecin) and chemotherapeutic agents |
| 02/04/2010 | US20100028337 Methods and compositions for modulating hyperstabilized c-met |
| 02/04/2010 | US20100028336 Anti-Mesothelin Antibodies |
| 02/04/2010 | US20100028335 Compositions and Methods to Treat Bone Related Disorders |
| 02/04/2010 | US20100028331 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 02/04/2010 | US20100028322 Antimetastatic effect on human cell disorders |
| 02/04/2010 | US20100028298 Interferon type i supporting compounds |
| 02/04/2010 | US20100028262 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 02/04/2010 | US20100028257 Pharmaceutical compounds |
| 02/04/2010 | US20100028256 Differential gene expression in physiological and pathological angiogenesis |
| 02/04/2010 | DE102008035552A1 Substituierte Pyridine und ihre Verwendung Substituted pyridines and their use |
| 02/04/2010 | CA2738510A1 6-substituted isoflavonoid compounds and uses thereof |
| 02/04/2010 | CA2732948A1 Use of a soluble form of hla-g in the treatment of abnormal b-lymphocyte proliferation |
| 02/04/2010 | CA2732721A1 Melk epitope peptides and vaccines containing the same |
| 02/04/2010 | CA2732632A1 Psma-binding agents and uses thereof |
| 02/04/2010 | CA2732536A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs |
| 02/04/2010 | CA2732497A1 Use of opioids or opioid mimetics for the treatment of resistant cancer patients |
| 02/04/2010 | CA2732437A1 Toll-like receptor agonist formulations and their use |
| 02/04/2010 | CA2732436A1 Vaccine against hpv |
| 02/04/2010 | CA2732290A1 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof |
| 02/04/2010 | CA2732232A1 3',6-substituted indirubins and their biological applications |
| 02/04/2010 | CA2732205A1 Composition useful for the prevention or reduction of the progression of prostate cancer |
| 02/04/2010 | CA2732186A1 Imidazothiadiazole derivatives |
| 02/04/2010 | CA2731919A1 New compounds |
| 02/04/2010 | CA2731873A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2731323A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 02/04/2010 | CA2730659A1 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 02/04/2010 | CA2730489A1 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 02/04/2010 | CA2730428A1 Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase |
| 02/04/2010 | CA2729045A1 Pyrimidine compounds, compositions and methods of use |
| 02/04/2010 | CA2728096A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/04/2010 | CA2718750A1 Preparation method of biodegradable micro-particles containing drugs |
| 02/03/2010 | EP2149582A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |
| 02/03/2010 | EP2149580A1 Mimetics of sulfated oligosaccharides |
| 02/03/2010 | EP2149574A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof |
| 02/03/2010 | EP2149567A1 Cyclic polyamines for binding phosphatidylserine |
| 02/03/2010 | EP2149561A1 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/03/2010 | EP2149553A1 3', 6-substituted indirubins and their biological applications |
| 02/03/2010 | EP2149552A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors |
| 02/03/2010 | EP2149381A2 Method of treating malignancies through induction of blood immune responses |
| 02/03/2010 | EP2149372A1 Use of opioids or opioid mimetics for the treatment of resistant cancer patients |
| 02/03/2010 | EP2148931A2 Drug discovery methods for aurora kinase inhibitors |
| 02/03/2010 | EP2148886A1 Tubulysine derivatives |
| 02/03/2010 | EP2148880A1 P70 s6 kinase inhibitors |
| 02/03/2010 | EP2148877A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 02/03/2010 | EP2148875A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148874A1 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148861A1 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 02/03/2010 | EP2148858A1 Inhibitors of iap |
| 02/03/2010 | EP2148690A1 Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith |
| 02/03/2010 | EP2148689A1 Compositions comprising an extract of tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases |
| 02/03/2010 | EP2148677A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| 02/03/2010 | EP2148676A1 Use of sapacitabine to treat proliferative disease |
| 02/03/2010 | EP2148675A1 Anti-cancer medicine both for diagnosing and treating cancer |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | EP1421938B1 Antitumor agents and process for producing the same |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/03/2010 | CN101638411A Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 02/03/2010 | CN101637624A Medical devices containing rapamycin analogs |
| 02/03/2010 | CN100586484C Thorium-227 for use in radiotherapy of soft tissue disease |
| 02/03/2010 | CN100586444C Method of processing ginseng for medicinal use and composition |
| 02/02/2010 | US7655795 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 02/02/2010 | US7655780 Integrin-linked kinase and its uses |
| 02/02/2010 | US7655771 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 02/02/2010 | US7655755 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 02/02/2010 | US7655753 Conjugate |
| 02/02/2010 | US7655696 Highly efficacious and highly safe composition of a Stilbene derivative and a platinum coordination compound cis-diaminedichloroplatinum (II) |
| 02/02/2010 | US7655694 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655674 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell |
| 02/02/2010 | US7655669 Pyrimidineamide derivatives and the use thereof |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655661 Prodrugs of CC-1065 analogs |
| 02/02/2010 | US7655660 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide |
| 02/02/2010 | US7655654 Tetrazole substituted quinazoline compounds for antiproliferation agents |
| 02/02/2010 | US7655651 Biphenyl-4-carboxylic acid (4-chloro-3-{7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-2-oxo-1,4-dihydro-2H-pyrimido[4,5-d]pyrimidin-3-yl}-phenyl)-amide; protein kinase inhibitors |
| 02/02/2010 | US7655649 Inhibitors of Akt activity |
| 02/02/2010 | US7655640 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 02/02/2010 | US7655631 Pharmaceutical preparations and methods for inhibiting tumors |
| 02/02/2010 | US7655459 Enhancer contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells |
| 02/02/2010 | US7655458 Endostatin for use in the treatment of cancer and tumor metastasis |
| 02/02/2010 | US7655426 Ephrin-B receptor protein involved in carcinoma |
| 02/02/2010 | US7655412 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |